Article Text

other Versions

PDF
Original research
Analysis of utilization patterns of vertebroplasty and kyphoplasty in the Medicare population
  1. Laxmaiah Manchikanti1,2,
  2. Vidyasagar Pampati3,
  3. Joshua A Hirsch4
  1. 1Pain Management Center of Paducah, Paducah, Kentucky, USA
  2. 2Department of Anesthesiology and Perioperative Medicine, University of Louisville, Louisville, Kentucky, USA
  3. 3Department of Statistics, Pain Management Center of Paducah, Paducah, Kentucky, USA
  4. 4Department of NeuroInterventional Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
  1. Correspondence to Dr Laxmaiah Manchikanti, Pain Management Center of Paducah, 2831 Lone Oak Road, Paducah, KY 42003, USA; drlm{at}thepainmd.com

Abstract

Objective To determine the pattern of utilization of vertebral augmentation procedures including vertebroplasty and kyphoplasty of the lumbar and thoracic spine in the Medicare population in the USA.

Methods This analysis was performed using a standard 5% national sample of the Centers for Medicare and Medicaid Services physician outpatient billing claims from 2001 to 2008 and the Physician/Supplier Procedure Summary Master File for 2009 and 2010. Overall characteristics of utilization patterns for vertebral augmentation procedures were evaluated using multiple variables.

Results From 2002 to 2010, vertebroplasty procedures decreased overall by 24.6% with an average annual decrease of 3.5% per 100 000 Medicare population; from 2006 to 2010 the declines were 42.4% overall and 12.9% annually. From 2006 to 2010, kyphoplasty procedures increased overall by 0.8% with an annual average increase of 0.2% per 100 000 Medicare population.

Conclusion Analysis of growth patterns of vertebroplasty and kyphoplasty in the Medicare population from 2002 to 2010 illustrates a lack of growth of kyphoplasty and a decline in vertebroplasty procedures.

Statistics from Altmetric.com

Footnotes

  • Funding The data from the Centers for Medicare and Medicaid Services (CMS) were purchased for $16 000 by the American Society of Interventional Pain Physicians (ASIPP). There was no other funding. Internal resources were used in preparing this manuscript.

  • Competing interests JH is a consultant for CareFusion and serves on the Steering Committee for the KAVIAR trial (volunteer position) and on the Data and Safety Monitoring Board (DSMB): CEEP trial (volunteer position).

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.